key: cord-0775877-sihwtxfp authors: Etaware, P. M. title: Influenza outbreak, disease transmission rate and mortality risk in the United States (2021 to 2050 Projection) date: 2021-04-20 journal: nan DOI: 10.1101/2021.04.16.21255632 sha: 83febaaf765e76b862ff1d4b0590a32eec05ad8e doc_id: 775877 cord_uid: sihwtxfp Influenza and COVID-19 pandemics are among the deadliest respiratory diseases recorded in the history of humanity. Influenza infections are difficult to diagnose and nearly impossible to predict because the disease symptoms changes as the pathogen(s) evolve. The U.S. was the case study for this research (Latitude: 37.0902 {degrees} N and Longitude: 95.7129 {degrees} W). The principle employed in the design of the influenza forecast model was the Integrated Independent System of Disease Prediction (IISDP), where the functionality of one forecast model depends on the predictive capacity of one or more forecast models. It was predicted that 49,734,427 individuals will be infected in 2021 out of the current estimation of 322,900.000 U.S. citizens (only about 1.5 percent of the total population). The situation was estimated by Etaware-Pred-2021 to worsen in 2050 (300,803,433 infected individuals out of the estimated 400,000,000 U.S. citizens), with a geometric increase in the ratio of infected individuals from 1.5 percent (in 2021) to 75.2 percent (in 2050), if necessary health precautions fail. unless there are potent influenza vaccines in circulation, total compliance to influenza vaccination and a high level of personal hygiene among U.S. citizens, influenza infection will become a global threat to humanity. These situations can be averted if the U.S. citizens act accordingly. where it spread northwards to North Africa and Europe, and westwards, through travels aboard 69 European vessels, across the Atlantic Ocean to America, Oceania/Australia, Antarctica and the 70 rest of the world, causing another wave of disease pandemic which lasted for 2 years (1557-1558) 71 [8]. The influenza disease morbidity was relatively high as it spread faster, fortunately, the 72 mortality (Death rate) was low and only restricted to immunocompromised or immunosuppressed 73 individuals, children and the aged [8] . This was the first pandemic recorded in history to be 74 associated with miscarriages and foetal mortality [11] . Indeed, it was undoubtedly the historical 75 advent of the spread of Influenza pandemic worldwide. 76 Currently, in the 21 st century, the United States is one of the most affected countries worldwide, 77 with severe and recurrent influenza attacks. Well over 30.9 million cases were reported in 2017 78 and another 14.5 million influenza-related cases recorded in hospitals within the United States 79 alone. Also, about 143 deaths (Influenza and Pneumonia) were recorded in every 1,000,000 80 individuals encountered in 2017 [12] . Initially, Heart disease was the leading cause of death in the 81 United States, accounting for 23% of all deaths, alongside cancer, accidents, chronic lower 82 respiratory diseases and cerebrovascular diseases etc., but influenza and pneumonia are fast 83 becoming a nightmare in recent years [12] . Influenza infections are associated with thousands of 84 deaths every year in the United States, mostly among adults aged ≥65 years [13] . 149 The morbidity data for influenza outbreak in the U.S. was obtained from the published articles of 150 Elflein [18] , CDC [19] and Wikipedia [20] . The data collected was from 2010-2020 (10years). 151 152 The stats for annual influenza vaccination in the United States was obtained from Elflein [21] . 153 154 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 20, 2021. ; https://doi.org/10.1101/2021.04.16.21255632 doi: medRxiv preprint 2.9 Mean, standard deviation and standard error of the mean 176 The population mean (μ), standard deviation (σ) and standard error of the mean (σ ẍ ) were 177 calculated by the formulae given below: 178 The mortality rate is a measure of the time limit through infection to death in a given population. Excel (2016). The quality of each models was determined by the values of the coefficient and 194 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. annually (Acquired Immunity) and the ratio of disease resistant to susceptible individuals in the 206 population (Herd Immunity), vis a vis the U.S. population dynamics (migration, natality and 207 mortality). Estimated data for vaccination was the most convenient and reliable source of predictor 208 for the disease, as vaccination stimulates innate immunity which is the fundamental mechanism 209 for collective defence (Herd Immunity). 210 The model for vaccination was carefully structured using the multiple regression equation (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 20, 2021. ; https://doi.org/10.1101/2021.04.16.21255632 doi: medRxiv preprint The structured model was further validated using real-life data recorded for U.S. senior citizens. 241 There was no significant difference in the estimated number of U.S. senior citizens vaccinated over 242 the years (2015 -2020) and that of the actual values recorded by the U.S. CDC (T-test = -0.53, P 243 = 0.62). Also, there was no significant difference in the estimated immunity level and those 244 calculated for the actual population of senior citizens in the United States from 2015 to 2020 (T-245 test = -0.62, P = 0.56) as shown in Table 1 . The correlation between the predicted and actual results 246 was 0.84, while the coefficient of correlation was 0.71 (Table 1) (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 20, 2021. ; https://doi.org/10.1101/2021.04.16.21255632 doi: medRxiv preprint (≥65years) turned out for vaccination in 2020 (Table 2) , amidst the rising cases of influenza 258 outbreak and the challenges associated with the geometric increase in population over the years. 259 Also, the immunity level of the U.S. populace to influenza infection was on the decrease over the 260 years i.e. From 52.3% in 2011 to 50.0% in 2020 (Table 2) . 261 Table 2 . Estimated values for influenza vaccination in the U.S. based on age distribution 262 Note: The A.I. was calculated as a percentage of each vaccinated proportion in relation to the total 263 population and that of the population of each age distribution presented in Supplementary file "S1". 264 A.I. = Acquired Immunity 265 266 The acquired immunity conferred on the populace through mass vaccination was further used to 267 structure a predictive model for determination or estimation of annual increase in influenza 268 infection rate within the United States (Fig 4) . (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 20, 2021. Table 3 . 296 297 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The predictors defined by the multiple regression models developed in the course of this research 302 and those estimated by other researchers or those linked to the United States census board (actual 303 and computer simulations) and the Centres for Disease Control were tested for their reliability and 304 relatedness to influenza outbreak in the U.S. using PPMC, cluster analysis (Fig 5) or scatterplots 305 fitted with regression lines (Fig 6) and connect (trend) lines (Fig 7) . Majority of the predictors 306 tested had >85% relatedness to the response variable, with a correlation factor of 1.00. The structured models were incorporated into the influenza outbreak forecast system to enhance 313 the model's performance, predicative precision and result accuracy (Fig 8) . The developed model 314 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (Table 4) . 348 (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The minimum expected turn out for mass vaccination against influenza infection of the United 353 States' citizen was shown in Table 5 . It is expected that the number of people that will be 354 (Table 5) . 360 It is expected that in 2050, the U.S. population will almost or totally achieve herd immunity against 361 influenza infection with an average estimated value of 70.7% of the total population immune 362 against the disease. It is also expected that 85.9% of the total population of infants and youths 363 below 18 years will be immune against influenza infection, 60.9% of the population of young 364 adults (age between 18 and 64 years) will be immune against the infection, while 82.5% of senior 365 citizens of the United States will have acquired immunity against influenza infection in 2050, 366 provided that there are potent influenza vaccines available or in circulation for mass vaccination 367 and the perception of the populace towards the reception of vaccines increase with the current 368 awareness campaign against respiratory diseases (Table 6) . (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. population and that of the population of each age distribution presented in Supplementary file 382 "S7". 383 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Due to the anticipated increase in the immunity level of the U.S. population, it is expected that in 384 2050, the susceptibility of humans to influenza infection in the United States will drastically reduce 385 by almost half of the value calculated in 2021 i.e. from 0.49 to 0.29, while that of infants and young 386 adults below the age of 18 years will be reduced by two-third of the value recorded in 2021 (0.42 387 in 2021 to 0.14 in 2050) as shown in Table 7 , if only strict compliance to influenza vaccination is 388 upheld. 389 It was predicted that 49,734,427 individuals will be infected in 2021 out of the current estimation 390 of 322,900.000 U.S. citizens i.e. 1.5% of the total population of U.S. citizens in 2021 (Table 8) . (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 20, 2021. ; https://doi.org/10.1101/2021.04.16.21255632 doi: medRxiv preprint The number of U.S. citizens vaccinated against influenza infection annually and the rate at which 415 influenza and pneumonia kill infected individuals annually were used as determinants (predictors) 416 for the development of another model for the estimation of deaths associated with influenza and 417 pneumonia in the United States. The developed model was christened Etaware-Mort-2021 (Fig 9) . 418 (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It was estimated that the death toll from influenza and pneumonia in the United States will increase 442 arithmetically from 12,909 casualties in 2021 to 23,133 deaths in 2050 as shown in Fig 11. Also, 443 it is expected that the rate of death from the disease will increase from 40 persons in 2021 to 58 444 persons in 2050 per unit population size of 1,000,000 individuals encountered or censored in the 445 United States (Fig 12) . Fortunately, there is a decline in the death risk associated with contracting 446 the influenza virus (Fig 13) (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 20, 2021. The author declares that there is no competing or conflicting interest in the publication of this 507 article. 508 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. percentage of the population: persons in selected age groups as a percentage of the total 563 U.S. population, and children ages 0-17 as a percentage of the dependent population, 564 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 20, 2021. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 20, 2021. ; https://doi.org/10.1101/2021.04.16.21255632 doi: medRxiv preprint All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 20, 2021. ; https://doi.org/10.1101/2021.04.16.21255632 doi: medRxiv preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 20, 2021. ; https://doi.org/10.1101/2021.04.16.21255632 doi: medRxiv preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 20, 2021. ; https://doi.org/10.1101/2021.04.16.21255632 doi: medRxiv preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 20, 2021. ; https://doi.org/10.1101/2021.04.16.21255632 doi: medRxiv preprint All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 20, 2021. ; https://doi.org/10.1101/2021.04.16.21255632 doi: medRxiv preprint All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 20, 2021. ; https://doi.org/10.1101/2021.04.16.21255632 doi: medRxiv preprint Pandemic influenza. World Health Organization regional office for Europe 2. WHO, 2009. Influenza. World Health Organization regional office for 500-year evolution of the term epidemic The Flu Pandemic and You: A Canadian Guide Immunogenicity, Efficacy, and Effectiveness of Influenza Vaccines No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity 7. WHO, 2020. Influenza. World Health Organization regional office for Africa Pandemic influenza -including a risk 537 assessment of "H5N1 Pandemic influenza: certain 540 uncertainties History of Swine Flu. JK Science. PG Department of Pharmacology, 543 Government Medical College The Story of Influenza Institute of Medicine (US) Forum on Microbial Deaths by influenza and pneumonia in the U.S. 1950-2017. Health, 548 Pharma and Medtech -Statista Estimates of Deaths Associated with Seasonal Influenza in the United States United States population projections for Population division, U. S. 557 Department of Commerce, Economics and Statistics Administration Estimated number of influenza cases in the United States from 2010 to 567 2019. Health, Pharma and Medtech -Statista CDC, 2020. Disease burden of influenza. Page last reviewed: 05/10/2020. 9pg Flu vaccine coverage in the U.S (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.